NCT01989689View on ClinicalTrials.gov

Etanercept and Vascular Function in Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

PSORIASIS

Interventions

DRUG

Etanercept

Etanercept 50mg twice weekly

DRUG

Placebo

Trial Locations (1)

30322

Emory University, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Emory University

OTHER

NCT01989689 - Etanercept and Vascular Function in Psoriasis | Biotech Hunter | Biotech Hunter